Radiation for Stage 2 Breast Cancer: 92 Real Stories

Stage II Breast Cancer: Mia's Patient Story

Patient Info: Mia | Stage II

Mia completed treatment and continued to manage its physical, emotional, and financial effects.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Mina's Survivor Story

Patient Info: Mina | Stage II

Mina said she was in remission and no longer needed medication.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Nelly's Patient Story

Patient Info: Nelly | Stage II

Nelly said she was in remission after mastectomy, chemotherapy, and radiation and remained on hormone therapy.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Camila's Survivor Story

Patient Info: Camila, Female, 40s | Stage II

Camila completed the recommended treatment plan and moved into survivorship, focusing on her daughter, family travel and returning to work.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Lilibeth's Survivor Story

Patient Info: Lilibeth | Stage II

Lilibeth described her stage 2 breast cancer as being in remission after completing most treatment and remained on hormone therapy.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Lily's Patient Story

Patient Info: Lily | Stage II

Lily had undergone lumpectomy, lymph-node surgery, chemotherapy, and radiation for stage 2 breast cancer and focused on staying positive after treatment.

Our Cancer StoriesRead more →

Stage II Breast Cancer: Aishah's Survivor Story

Patient Info: Aishah, Female, 50s | Stage II

Aishah completed mastectomy, chemotherapy and radiation and described herself as being in remission. She continued regular mammograms and follow-up because of fear of recurrence.

Our Cancer StoriesRead more →

Stage II BRCA1 Invasive Ductal Carcinoma: Stephanie's Patient Story

Patient Info: Stephanie Hargis, Female, Under 40 | Stage II

Biomarkers: ER-negative; PR-negative; HER2-negative; BRCA1 mutation

Stephanie had Stage II triple-negative breast cancer with BRCA1 mutation, then a local recurrence in April 2023 without distant spread; after surgery, chemotherapy, Keytruda, radiation, and Lynparza, she remained in ongoing post-recurrence treatment.

BreastCancer.org (ES)Read more →

Stage II Breast Cancer: Sylvie's Patient Story

Patient Info: Sylvie, Female, 40s | Stage II

Biomarkers: Hormone-sensitive breast cancer

Sylvie completed treatment for breast cancer and later treatment for recurrence, with a continued emphasis on screening, resilience, and life after treatment.

Fondation ARCRead more →

Stage II Breast Cancer: Danielle's Survivor Story

Patient Info: Danielle, Female, 60s | Stage II

Danielle was listed as cancer-free after treatment for Stage II breast cancer that included mastectomy, chemotherapy, 5 weeks of radiation, and immunotherapy.

Fondation ARCRead more →

Stage II Breast Cancer: Alba's Patient Story

Patient Info: Alba, Female, 50s | Stage II

Alba was undergoing Stage II breast cancer care, had chosen modern medicine after seeking a second opinion and trying alternative approaches, and was on hormone therapy while focusing on recovery.

Our Cancer StoriesRead more →

Stage II Invasive Lobular Carcinoma: Kristel's Survivor Story

Patient Info: Kristel, Female, Under 40 | Stage II

After double mastectomy and 25 rounds of radiation for Stage II invasive lobular carcinoma, Kristel moved into post-treatment support and created a virtual group for others with ILC.

Lobular Breast Cancer AllianceRead more →

Stage II Invasive Lobular Carcinoma: Alma's Patient Story

Patient Info: Alma, Female | Stage II

Alma had Stage II invasive lobular carcinoma treated with lumpectomy, chemotherapy, radiation, and planned 10 years of tamoxifen, then found a local recurrence 4.5 years after diagnosis.

Lobular Breast Cancer AllianceRead more →

Stage II Invasive Ductal Carcinoma: Roxanne's Survivor Story

Patient Info: Roxanne, Female, Under 40 | Stage II

Biomarkers: Genetic testing reported no hereditary/family-risk finding; tumor biomarker status not reported

Completed chemotherapy, surgery, and radiation for Stage IIB invasive ductal carcinoma; the source title identifies no evidence of disease after treatment, and she described herself as a survivor after finishing treatment on 28 April 2025.

breastcancer.orgRead more →

Stage II HR-Positive Invasive Lobular Carcinoma: Eutha's Survivor Story

Patient Info: Eutha, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

Eutha completed clinical-trial immunotherapy, right mastectomy with lymph-node removal, chemotherapy, radiation and reconstruction for Stage II ER-positive, PR-positive, HER2-positive breast cancer, and returned to work and community life; no explicit NED/cancer-free status was provided.

Memorial Sloan KetteringRead more →

Stage II Breast Cancer: Nicole's Survivor Story

Patient Info: Nicole Grogan, Female, 40s | Stage II

Nicole completed surgery, chemotherapy, radiation and the exercise trial, and had no evidence of disease at her July 2019 appointment.

Memorial Sloan KetteringRead more →

Stage II Invasive Ductal Carcinoma: Dwan's Survivor Story

Patient Info: Dwan Thomas, Female | Stage II

Biomarkers: HER2-negative; estrogen-positive

Dwan completed treatment for Stage II HER2-negative, estrogen-positive invasive ductal carcinoma in 2017 and later became active in MD Anderson advocacy and fundraising efforts.

MD AndersonRead more →

Stage II Breast Cancer: Naomi's Patient Story

Patient Info: Naomi Arbel-Brodd, Female | Stage II

Twenty years after her 2006 diagnosis, she had returned to UT MD Anderson as a weekly volunteer supporting other women receiving breast cancer care.

MD AndersonRead more →

HER2-Positive Breast Cancer Treatment Followed by Multiple Myeloma

Patient Info: Anonymized, female, 50s | Stage II

Biomarkers: ER-negative; PR-negative; HER2 3+; Ki-67 70%

Postoperative imaging showed no breast cancer recurrence or distant metastasis, and the breast cancer was described as stable when a separate multiple myeloma diagnosis was made.

PubMed CentralRead more →

Stage II Breast Cancer: Renée's Survivor Story

Patient Info: Renée, Female, Under 40 | Stage II

Renée described her health as stable and her treatment as working. She remained on a long-term hormone-based anti-cancer regimen and was still healing from reconstruction complications rather than describing herself as cancer-free.

The Patient StoryRead more →

Stage II Triple-Negative Breast Cancer: Lucy's Survivor Story

Patient Info: Lucy, Female, Under 40 | Stage II

Biomarkers: Germline BRCA1 mutation; triple-negative breast cancer

Surgical pathology was all clear on June 17 after a strong chemotherapy response. Lucy described herself as cancer-free and continued oncology reviews every 3–4 months while planning delayed reconstruction.

The Patient StoryRead more →

Stage II HR-Positive Breast Cancer: Bethany's Patient Story

Patient Info: Bethany W., Female, Under 40 | Stage II

Biomarkers: ER-positive; hormone-positive

As of June 2026, Bethany described care for late Stage II/early Stage III ER-positive breast cancer, beginning with AC chemotherapy and Taxol after scans showed no distant spread, with surgery, radiation, and hormone therapy planned as next phases.

The Patient StoryRead more →

Stage II HR-Positive Invasive Ductal Carcinoma: Doreen's Patient Story

Patient Info: Doreen, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of June 2026, Doreen had completed TCHP chemotherapy with a complete response before surgery and had undergone lumpectomy and radiation for Stage IIA triple-positive breast cancer.

The Patient StoryRead more →

Stage II Invasive Ductal Carcinoma: Margaret's Survivor Story

Patient Info: Margaret, Female | Stage II

Biomarkers: Onco-typing score 18; hormone-responsive tumor described; exact receptor status not reported

As of June 2026, Margaret’s story described completed surgery, chemotherapy, radiation, and later reconstruction for Stage II IDC/DCIS breast cancer, with survivorship focused on recovery, neuropathy, and integrative support rather than an explicit NED claim.

The Patient StoryRead more →